Home LiteratureArticle Details
PMID: 3056253 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Antimicrobial agents and chemotherapy ·Vol. 32 ·No. 8 ·1988-08-00 ·Pages 1187-91

Cohen SP, Hooper DC, Wolfson JS, Souza KS, McMurry LM, Levy SB

Abstract

Escherichia coli was shown to have an energy-dependent reduced uptake of the fluoroquinolone antimicrobial agent norfloxacin. Studies of everted inner membrane vesicles suggested that this reduced accumulation involved a carrier-mediated norfloxacin active efflux generated by proton motive force with an apparent Km of 0.2 mM and a Vmax of 3 nmol min-1 mg of protein-1. Other hydrophilic, but not hydrophobic, quinolones competed with norfloxacin for transport. Porin (OmpF)-deficient E. coli cells were twofold less susceptible to norfloxacin and showed twice as much energy-dependent reduction in drug uptake. However, active efflux assayed in everted vesicles from the OmpF strain was unchanged compared with that in the parental strain. These findings suggest that in the OmpF mutant decreased outer membrane permeability, combined with active efflux across the inner membrane, in some manner results in decreased steady-state uptake of norfloxacin and lowered drug susceptibility.

MeSH Terms
Anti-Infective Agents/metabolism Biological Transport, Active Cell Membrane/metabolism,ultrastructure Cell Membrane Permeability Ciprofloxacin/metabolism Enoxacin/metabolism Escherichia coli/metabolism,ultrastructure Kinetics Norfloxacin/metabolism Ofloxacin/metabolism Spheroplasts/metabolism
Chemicals
Anti-Infective Agents Enoxacin Ciprofloxacin Ofloxacin Norfloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Cohen S P
Department of Molecular Biology, Tufts University School of Medicine, Boston, Massachusetts 02111.
Hooper D C
Wolfson J S
Souza K S
McMurry L M
Levy S B
References (22)
22 references, click to expand
  1. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
    Antimicrob Agents Chemother. 1985 Nov;28(5):716-21 PMID: 2936302
  2. Mutants of Escherichia coli requiring methionine or vitamin B12.
    J Bacteriol. 1950 Jul;60(1):17-28 PMID: 15436457
  3. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):535-8 PMID: 3521490
  4. H+/ATP stoichiometry of proton pumps from Neurospora crassa and Escherichia coli.
    Arch Biochem Biophys. 1986 Jul;248(1):53-61 PMID: 2425739
  5. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
    Antimicrob Agents Chemother. 1986 Aug;30(2):248-53 PMID: 3532944
  6. Expression of a multidrug-resistance gene in human tumors and tissues.
    Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9 PMID: 2432605
  7. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.
    Science. 1987 Feb 20;235(4791):899-901 PMID: 3544220
  8. Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.
    Antimicrob Agents Chemother. 1987 Sep;31(9):1348-54 PMID: 2823695
  9. Norfloxacin resistance in a clinical isolate of Escherichia coli.
    Antimicrob Agents Chemother. 1987 Oct;31(10):1640-1 PMID: 2829712
  10. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  11. The role of energy coupling in the transport of beta-galactosides by Escherichia coli.
    J Biol Chem. 1966 May 25;241(10):2200-11 PMID: 5330114
  12. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.
    Biochim Biophys Acta. 1973 Oct 25;323(3):466-83 PMID: 4796512
  13. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):3974-7 PMID: 7001450
  14. Reduction in three iron-regulated outer membrane proteins and protein a by the Escherichia coli K-12 perA mutation.
    J Bacteriol. 1981 May;146(2):804-7 PMID: 6452446
  15. The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12.
    J Mol Biol. 1981 Feb 15;146(1):23-43 PMID: 7021856
  16. Energy-dependent arsenate efflux: the mechanism of plasmid-mediated resistance.
    Proc Natl Acad Sci U S A. 1982 Oct;79(20):6114-8 PMID: 6755462
  17. Energetics of plasmid-mediated arsenate resistance in Escherichia coli.
    Proc Natl Acad Sci U S A. 1982 Oct;79(20):6119-22 PMID: 6755463
  18. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline.
    J Bacteriol. 1983 Aug;155(2):531-40 PMID: 6348022
  19. Susceptible Escherichia coli cells can actively excrete tetracyclines.
    Antimicrob Agents Chemother. 1983 Oct;24(4):544-51 PMID: 6418064
  20. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Cancer Res. 1985 Apr;45(4):1687-91 PMID: 3919944
  21. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  22. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Apr;29(4):639-44 PMID: 3010850
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1988-08-00
Pages
1187-91
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC172374
Subset
IM
Grants
NIAID NIH HHS · AI16756 · United States
NIAID NIH HHS · AI23988 · United States
NHLBI NIH HHS · T32 HL07437 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]